Kevin Lee

Kevin Lee is currently the Chief Executive Officer at Bicycle Therapeutics. Prior to this, they held various positions at Pfizer and GSK. Kevin started their career as a group leader at Parke Davis Research Cambridge UK in 1995. In 2004, they became the VP and Head Epinova DPU at GSK. Kevin held this position until 2012 when they moved to Pfizer as CSO for Orphan and Genetic Diseases. Kevin remained at Pfizer until 2015 when they took their current role at Bicycle Therapeutics.

Nick Keen - Chief Scientific Officer, Lee Kalowski - President and Chief Financial Officer, and Dominic Smethurst - Chief Medical Officer report to Kevin Lee.